Rheumatology Dr. Mert Öztaş
✓ Medically verified profileDr. Mert Öztaş
✓ Medically verified profile
Quick answer
Dr. Mert Öztaş is a Rheumatology specialist at Acibadem Atakent Hospital in İstanbul with 14+ years of experience.
He treats retroperitoneal fibrosis, giant cell arteritis, dermatomyositis, statin-induced dermatomyositis, inflammatory rheumatic diseases, and autoimmune musculoskeletal diseases, and provides rituximab, colchicine, and hydroxychloroquine therapy in rheumatic diseases. He consults in Turkish and English and offers online video consultation.
About Dr. Mert Öztaş
Dr. Mert Öztaş is a rheumatologist with 14 years of experience. His listed areas of expertise include inflammatory rheumatic diseases, autoimmune musculoskeletal diseases, retroperitoneal fibrosis, giant cell arteritis, dermatomyositis, rituximab therapy for retroperitoneal fibrosis, and colchicine therapy in rheumatic diseases.
Dr. Öztaş completed rheumatology specialization at Istanbul University Cerrahpasa Faculty of Medicine in 2021. He was at Istanbul University Cerrahpasa Medical Faculty, Rheumatology, from 2018 to 2021, and at Health Sciences University Istanbul Training and Research Hospital from 2021 to 2023. He joined Acibadem Health Group in 2023. He practises at Acibadem Atakent Hospital in İstanbul, Türkiye.
The profile lists 3 professional bodies, among them EMEUNET (Emerging EULAR Network), the Turkish Rheumatology Association, and TRD-G (Turkish Rheumatology Association-Young).
The profile lists 6 publications dated between 2017 and 2023. Their subjects include retroperitoneal fibrosis and rituximab, giant cell arteritis, and dermatomyositis associated with atorvastatin. Other listed papers address rheumatic diseases in relation to colchicine or hydroxychloroquine and statistical significance thresholds in observational studies and randomized controlled trials.
Dr. Öztaş speaks Turkish and English. Online consultation is available, allowing patients abroad to speak with the doctor before travelling.
Areas of Expertise
Conditions treated and procedures performed by this specialist.
Education
- 2021Istanbul University Cerrahpasa Faculty of Medicine Rheumatology
- 2018Istanbul University Cerrahpaşa Faculty of Medicine Internal Medicine
- 2012Istanbul University Cerrahpasa Faculty of Medicine
Professional Experience
- 2023Acibadem Health Group
- 2021–2023Health Sciences University Istanbul Training and Research Hospital
- 2018–2021Istanbul University Cerrahpasa Medical Faculty, Rheumatology
- 2013–2018Istanbul University Cerrahpasa Faculty of Medicine, Internal Medicine
- 2012Devrek State Hospital
Professional Memberships
- TRD-G (Turkish Rheumatology Association-Young)
- Turkish Rheumatology Association
- EMEUNET (Emerging EULAR Network)
Selected Publications
- Rituximab in the management of retroperitoneal fibrosis: A single tertiary rheumatology care center experience Int J Rheum Dis. 2023 Jun 26. doi: 10.1111/1756-185X.14798. Oztas M, Altun I, Ayla AY, Cerme E, Demirdag C, Asa S, Sonmezoglu K, Ugurlu S.
- Frequency and severity of COVID-19 in patients with various rheumatic diseases treated regularly with colchicine or hydroxychloroquine. J Med Virol. 2022 Jul;94(7):3431-3437. Oztas M, Bektas M, Karacan I, Aliyeva N, Dag A, Aghamuradov S, Cevirgen SB, Sari S, Bolayirli M, Can G, Hatemi G, Seyahi E, Ozdogan H, Gul A, Ugurlu S
- Presentation characteristics and clinical outcome of patients with giant cell arteritis followed by a single center Turk J Med Sci. 2021 Sep 27. doi: 10.3906/sag-2102-263. Öztaş M, Özgül H, Seyahi E, Uğurlu S.
- Giant Cell Arteritis with Concomitant Chronic Myelomonocytic Leukemia Turk J Haematol. 2020 Jul 23. PMID: 32702949. Öztaş M, Muradov İ, Erçalışkan A, Demiröz AS, Batur Ş, Eşkazan AE, Uğurlu S.
- Changing the traditional p-value significance threshold to .005 does not decrease the number of statistically significant p-values in observational studies more than in randomized controlled trials. Clin Exp Rheumatol. 2020 Nov 17. Oztas M, Dincer ZT, Sut N, Yazici H.
- Atorvastatin-induced dermatomyositis. Rheumatol Int. 2017 Jul;37(7):1217-1219. PMID:28238074 Oztas M, Ugurlu S, Aydin O.
Frequently Asked Questions
What is Dr. Mert Öztaş's specialty?
Which hospital does Dr. Mert Öztaş practise at?
What languages can I use when consulting Dr. Mert Öztaş?
How can I book an appointment with Dr. Mert Öztaş?
Is an online video consultation available with Dr. Mert Öztaş?
How many years of experience does Dr. Mert Öztaş have?
Can international patients arrange treatment with Dr. Mert Öztaş?
How do I get a second opinion involving Dr. Mert Öztaş?
A dedicated team, from first message to follow-up
Our international patient office coordinates your appointment, travel and treatment at JCI-accredited Acıbadem hospitals — and stays with you in your own language, every step of the way.
Schedule your appointment with Dr. Mert Öztaş
Choose a date and time that suits you. Our international patient team will check availability and confirm your appointment — usually within 24 hours.
- 1Choose your date & timePick a preferred day and time slot for your visit.
- 2Share your detailsTell us how to reach you and anything we should know.
- 3We confirm with youOur team confirms the appointment by phone or email.
Request your appointment
This request goes directly to this doctor’s schedule.
Your information stays strictly confidential and is used only to arrange your care.
Hospitals
Medical Units
What patients say about Dr. Mert Öztaş
★★★★★From 2,400+ verified patient reviews“My arthritis treatment exceeded every expectation I had. Dr. Öztaş was calm, precise and deeply reassuring. I have already recommended Acibadem to my family.”
“Thanks to the team here, my liver care could not have gone better. Prof. Dr. Boztaş was calm, precise and deeply reassuring. Everything was clearly explained in my own language.”
“Years of worry ended once I came here for my reflux treatment. Prof. Dr. Öztaş made a stressful situation feel completely manageable. The international patient office coordinated everything perfectly.”